PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: PEG-rhG-CSF
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.